New research suggests that patients who come off new GLP-1 drugs like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who stop conventional lifestyle regimens.
Research printed in a leading health publication points out that while overweight individuals often shed substantial amounts of their total mass while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"Individuals buying these treatments must be aware of the danger of fast rebound weight gain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.
Such speed of recovery suggests a reversion to original mass within about one and a half years.
Analyzing Therapies
The analysis, which looked at 37 of trials involving thousands of participants, contrasted the outcomes of the injectable medications with older methods.
The team emphasize that individuals who shed pounds through dieting typically see a more gradual creep back—perhaps 100 grams monthly—after stopping.
Explaining the Rapid Rebound
Experts suggest the mechanism of the injections is key to understanding the heightened rebound.
GLP-1 drugs imitate a natural hormone called GLP-1, which moderates feelings of fullness.
"Long-term administration of the hormone levels far above than the body's typical production may cause the body to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this GLP-1 'fix' leads to appetite is no longer kept in check, making excessive eating a significant risk."
An Ongoing Issue?
The NHS advise the jabs for people with weight-linked health risks, accompanied by recommended lifestyle changes.
Many experts argue that, due to the high risk of relapse, the treatment should be considered long-term.
This view is echoed by pharmaceutical companies, who state that the results "underscore the chronic character of excess weight," akin to managing diseases like hypertension.
Patient Testimonies
Individuals who have come off the jabs describe a powerful resurgence of hunger.
"It was like a switch activating and you're instantly ravenous," described an individual.
The struggle is compounded if individuals have not developed permanent lifestyle or habit modifications during treatment.
Significant Use
Figures suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand remaining high.
- Adoption is greater among females than males.
- The 40s and 50s demographic shows the highest level of interest.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while the jabs are potent agents for shedding pounds, they are not a magic cure and long-term success likely depends on integrated lifestyle changes.
